AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32583567 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative capecitabine plus oxaliplatin (XELOX, arm C)
Number of subjects: 749
Study 36156308 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine intervention (video telemedicine contacts at 3, 6, and 9 months)
Number of subjects: 24
Study 36156308 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 24
Study 33522701 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise group (n = 68)
Number of subjects: 128
Study 33522701 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising group (n = 60)
Number of subjects: 128
Study 34371883 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin plus BHC (berberine, hesperidin, and chromium picolinate)
Number of subjects: 0
Study 34371883 — intervention group
Group type: COMPARATOR
Intervention: Metformin only (control group)
Number of subjects: 0
Study 33038320 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Stores 2020 strategy (intervention group)
Number of subjects: 20
Study 33038320 — intervention group
Group type: COMPARATOR
Intervention: Usual retail practice (control group)
Number of subjects: 20
Study 33686137 — intervention group
Group type: EXPERIMENTAL
Intervention: Visually impaired individuals
Number of subjects: 11030
Study 33686137 — intervention group
Group type: EXPERIMENTAL
Intervention: Mildly visually impaired individuals
Number of subjects: 11030
Study 33686137 — intervention group
Group type: EXPERIMENTAL
Intervention: Severely visually impaired individuals
Number of subjects: 11030
Study 33686137 — intervention group
Group type: COMPARATOR
Intervention: Non-visually impaired individuals
Number of subjects: 11030
Study 32660675 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined anthocyanins and bromelain supplement (BE)
Number of subjects: 18
Study 32660675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 35027477 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal 2-chloroprocaine 1% (27.8 mg estimated ED90 in cohort I, 28 mg fixed dose in cohort II)
Number of subjects: 90
Study 32678299 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot and back massage (6 sessions of 30 min, twice weekly for 3 weeks)
Number of subjects: 90
Study 35340044 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with potent topical corticosteroid (TCS) and handheld narrowband ultraviolet B
Number of subjects: 0
Study 34639418 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific core stability group (SCS; n = 7)
Number of subjects: 14
Study 34639418 — intervention group
Group type: COMPARATOR
Intervention: General core stability group (GCS; n = 7)
Number of subjects: 14
Study 35064741 — intervention group
Group type: EXPERIMENTAL
Intervention: Isha Upa Yoga
Number of subjects: 679
Study 35064741 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 679
Study 33045126 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulligan's mobilization with movement (MWM)
Number of subjects: 0
Study 33045126 — intervention group
Group type: COMPARATOR
Intervention: Standard post-operative rehabilitation program
Number of subjects: 0
Study 32418143 — intervention group
Group type: EXPERIMENTAL
Intervention: Co‐Plavix® (fixed‐dose combination of 100 mg acetylsalicylic acid and 75 mg clopidogrel)
Number of subjects: 171
Study 32418143 — intervention group
Group type: COMPARATOR
Intervention: Reference formulations (coadministration of individual formulations of 100 mg acetylsalicylic acid and 75 mg clopidogrel)
Number of subjects: 171
Study 35699476 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-delivered growth-mindset intervention
Number of subjects: 1996
Study 35699476 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 1996
Study 33470369 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% alcoholic chlorhexidine
Number of subjects: 70
Study 33470369 — intervention group
Group type: COMPARATOR
Intervention: 70% hydrated ethyl alcohol
Number of subjects: 70
Study 32948800 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise
Number of subjects: 15
Study 32948800 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 15
Study 32948800 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 15
Study 36174958 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase 2 trial with randomized evaluation of multiple doses
Number of subjects: 0
Study 36174958 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase 3 trial with selected dose
Number of subjects: 0
Study 36174958 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation studies
Number of subjects: 0
Study 33023852 — intervention group
Group type: EXPERIMENTAL
Intervention: Great Taste Less Waste (GTLW) intervention
Number of subjects: 502
Study 33023852 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 502
Study 36322594 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Treadmill Training (VRTT)
Number of subjects: 60
Study 36322594 — intervention group
Group type: COMPARATOR
Intervention: Conventional Treadmill Training (CTT)
Number of subjects: 60
Study 33923462 — intervention group
Group type: EXPERIMENTAL
Intervention: B.strong training program
Number of subjects: 1150
Study 34488824 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (1-hour sessions, twice a week for 12 weeks)
Number of subjects: 90
Study 34488824 — intervention group
Group type: COMPARATOR
Intervention: Sham (minimal) acupuncture (1-hour sessions, twice a week for 12 weeks)
Number of subjects: 90
Study 34488824 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 90
Study 34488824 — intervention group
Group type: COMPARATOR
Intervention: Sham (minimal) acupuncture
Number of subjects: 90
Study 32470139 — intervention group
Group type: EXPERIMENTAL
Intervention: IVP piperacillin/tazobactam
Number of subjects: 1813
Study 36062831 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR treatment (weekly for 3 to 9 months)
Number of subjects: 24
Study 616356781 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg daily for six weeks (Group A)
Number of subjects: 115
Study 616356781 — intervention group
Group type: COMPARATOR
Intervention: No finasteride (Group B)
Number of subjects: 115
Study 35578245 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150/300 mg
Number of subjects: 204
Study 35578245 — intervention group
Group type: COMPARATOR
Intervention: Placebo (switched to secukinumab at week 24)
Number of subjects: 204
Study 34922565 — intervention group
Group type: EXPERIMENTAL
Intervention: Gasless laparoscopic surgery (GLS)
Number of subjects: 105
Study 34922565 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 105
Study 33372125 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy (MBCT‐C)
Number of subjects: 52
Study 33372125 — intervention group
Group type: COMPARATOR
Intervention: Group Therapy (GT)
Number of subjects: 52
Study 33974623 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary schistosomiasis (Schistosoma haematobium infection)
Number of subjects: 200
Study 33974623 — intervention group
Group type: EXPERIMENTAL
Intervention: Intestinal schistosomiasis (Schistosoma mansoni infection)
Number of subjects: 200
Study 33974623 — intervention group
Group type: EXPERIMENTAL
Intervention: S. haematobium infection
Number of subjects: 200
Study 33974623 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrohaematuria and microhaematuria
Number of subjects: 200
Study 33974623 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for S. haematobium infection
Number of subjects: 200
Study 32530552 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with cystic fibrosis (CF) aged 13 to 18 years
Number of subjects: 135
Study 32530552 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers of children with cystic fibrosis (CF)
Number of subjects: 135
Study 32530552 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers of children with cystic fibrosis (CF) whose children had chronic Pseudomonas infection
Number of subjects: 135
Study 32530552 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers of children with cystic fibrosis (CF) after the teleconference interview
Number of subjects: 135
Study 32530552 — intervention group
Group type: COMPARATOR
Intervention: Healthy children aged 13 to 18 years
Number of subjects: 135
Study 36289153 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus GG)
Number of subjects: 2650
Study 36289153 — intervention group
Group type: COMPARATOR
Intervention: Usual care (without probiotics)
Number of subjects: 2650
Study 32753339 — intervention group
Group type: EXPERIMENTAL
Intervention: COSMOS intervention (Communication, Systematic pain management, Medication reviews, Organization of activities, Safety)
Number of subjects: 723
Study 32753339 — intervention group
Group type: EXPERIMENTAL
Intervention: COSMOS intervention
Number of subjects: 723
Study 32753339 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 723
Study 35068087 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg/d ifenprodil
Number of subjects: 0
Study 35068087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35068087 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/d ifenprodil
Number of subjects: 0
Study 34849615 — intervention group
Group type: EXPERIMENTAL
Intervention: Favipiravir plus standard care
Number of subjects: 500
Study 34849615 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 500
Study 36294315 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape (KT)
Number of subjects: 55
Study 36294315 — intervention group
Group type: COMPARATOR
Intervention: Sham tape (ST)
Number of subjects: 55
Study 32683574 — intervention group
Group type: EXPERIMENTAL
Intervention: Households experiencing IPV and food insecurity
Number of subjects: 0
Study 32683574 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal alcohol use
Number of subjects: 0
Study 32683574 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal depressed mood
Number of subjects: 0
Study 32683574 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric pregnancy (age 35 or older)
Number of subjects: 0
Study 32683574 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal HIV status
Number of subjects: 0
Study 33049424 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing-Threat
Number of subjects: 90
Study 33049424 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior-Threat
Number of subjects: 90
Study 33049424 — intervention group
Group type: COMPARATOR
Intervention: No-Threat
Number of subjects: 90
Study 35255220 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led social marketing intervention
Number of subjects: 392
Study 35255220 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 392
Study 32008296 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting heart rate increases (per 5 beats/minutes)
Number of subjects: 10212
Study 32008296 — intervention group
Group type: COMPARATOR
Intervention: Resting heart rate <70 beats/minutes (control group)
Number of subjects: 10212
Study 32008296 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased resting heart rate in women <60 years
Number of subjects: 10212
Study 32008296 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased resting heart rate in women ≥60 years
Number of subjects: 10212
Study 32008296 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting heart rate
Number of subjects: 10212
Study 34391233 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration exercise (WBVE)
Number of subjects: 21
Study 34391233 — intervention group
Group type: COMPARATOR
Intervention: Isometry group
Number of subjects: 21
Study 32889413 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized goal-directed therapy (GDT)
Number of subjects: 146
Study 32889413 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 146
Study 32889413 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized targets (irrespective of intervention)
Number of subjects: 146
Study 35325870 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massage
Number of subjects: 80
Study 35325870 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 80
Study 33587439 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine/lamivudine/tenofovir (DOR/3TC/TDF)
Number of subjects: 86
Study 33587439 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz/emtricitabine/tenofovir (EFV/FTC/TDF)
Number of subjects: 86
Study 35605652 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk score (PGS)
Number of subjects: 0
Study 35605652 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 0
Study 32557506 — intervention group
Group type: EXPERIMENTAL
Intervention: 1× PPI (Pantoprazole 40 mg 1×/day)
Number of subjects: 39
Study 32557506 — intervention group
Group type: EXPERIMENTAL
Intervention: 2× PPI (Pantoprazole 40 mg 2×/day)
Number of subjects: 39
Study 32557506 — intervention group
Group type: COMPARATOR
Intervention: Control group (after PPI therapy)
Number of subjects: 39
Study 36414172 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP+HA injection following arthrocentesis
Number of subjects: 3
Study 36414172 — intervention group
Group type: COMPARATOR
Intervention: PRP injection following arthrocentesis
Number of subjects: 3
Study 36414172 — intervention group
Group type: COMPARATOR
Intervention: HA injection following arthrocentesis
Number of subjects: 3
Study 32880220 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogens (0.45 mg/day) with progesterone (200 mg/day for 12 days/month)
Number of subjects: 0
Study 32880220 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17β‐estradiol (50 µg/day) with progesterone (200 mg/day for 12 days/month)
Number of subjects: 0
Study 32880220 — intervention group
Group type: COMPARATOR
Intervention: Placebo pills and patches
Number of subjects: 0
Study 32665311 — intervention group
Group type: EXPERIMENTAL
Intervention: Buparlisib (80 mg) plus carboplatin (AUC=5 every 3 weeks)
Number of subjects: 35
Study 32665311 — intervention group
Group type: EXPERIMENTAL
Intervention: Buparlisib (60 mg) plus lomustine (100 mg/m2 every 6 weeks)
Number of subjects: 35
Study 32665311 — intervention group
Group type: COMPARATOR
Intervention: Buparlisib (80 mg or 100 mg) plus carboplatin or buparlisib (60 mg) plus lomustine
Number of subjects: 35
Study 34756937 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive facial expressions (FEs) while eating raw broccoli
Number of subjects: 111
Study 34756937 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral facial expressions (FEs) while eating raw broccoli
Number of subjects: 111
Study 34756937 — intervention group
Group type: COMPARATOR
Intervention: Non-food control video
Number of subjects: 111
Study 35636766 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 120
Study 35636766 — intervention group
Group type: COMPARATOR
Intervention: No preparation (NMBP)
Number of subjects: 120
Study 34481464 — intervention group
Group type: EXPERIMENTAL
Intervention: Option B+ ART initiation
Number of subjects: 532
Study 34481464 — intervention group
Group type: COMPARATOR
Intervention: Non-disclosure of HIV status
Number of subjects: 532
Study 32363552 — intervention group
Group type: EXPERIMENTAL
Intervention: Antrostomy placed close to the base of the sinus floor (group base)
Number of subjects: 24
Study 32363552 — intervention group
Group type: EXPERIMENTAL
Intervention: Antrostomy placed 3-4 mm cranially to the sinus floor (group standard)
Number of subjects: 24
Study 33882864 — intervention group
Group type: EXPERIMENTAL
Intervention: CRADLE Vital Signs Alert Device
Number of subjects: 536223
Study 33882864 — intervention group
Group type: COMPARATOR
Intervention: Control period (no intervention)
Number of subjects: 536223
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar diagnostic facet joint nerve blocks
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical diagnostic facet joint nerve blocks
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic diagnostic facet joint nerve blocks
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar radiofrequency ablation
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic lumbar facet joint nerve blocks
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical radiofrequency ablation
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic cervical facet joint nerve blocks
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic therapeutic facet joint nerve blocks
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic intraarticular facet joint injections
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance of opioid analgesics during diagnosis
Number of subjects: 0
Study 32503359 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate sedation for therapeutic interventions
Number of subjects: 0
Study 34371806 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB (3 g/day for 12 weeks)
Number of subjects: 24
Study 34371806 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sorbitol powder)
Number of subjects: 24
Study 33176418 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal oxygen-ozone gas mixture injection
Number of subjects: 200
Study 34384109 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC)
Number of subjects: 21
Study 34384109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 32462979 — intervention group
Group type: EXPERIMENTAL
Intervention: umeclidinium/vilanterol (UMEC/VI)
Number of subjects: 2425
Study 32462979 — intervention group
Group type: COMPARATOR
Intervention: umeclidinium
Number of subjects: 2425
Study 32462979 — intervention group
Group type: COMPARATOR
Intervention: salmeterol
Number of subjects: 2425
Study 35435425 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 50
Study 35435425 — intervention group
Group type: COMPARATOR
Intervention: 2 mL of normal saline
Number of subjects: 50
Study 34543613 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole for 5 years (extended group)
Number of subjects: 2056
Study 34543613 — intervention group
Group type: COMPARATOR
Intervention: Letrozole for 2-3 years (control group)
Number of subjects: 2056
Study 34543613 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events in extended group
Number of subjects: 2056
Study 34543613 — intervention group
Group type: COMPARATOR
Intervention: Adverse events in control group
Number of subjects: 2056
Study 32248638 — intervention group
Group type: EXPERIMENTAL
Intervention: Biobehavioral intervention (12 weekly, 30-minute telehealth sessions)
Number of subjects: 31
Study 32248638 — intervention group
Group type: COMPARATOR
Intervention: Attention control telehealth phase (GROUP2 during weeks 1-12)
Number of subjects: 31
Study 32248638 — intervention group
Group type: EXPERIMENTAL
Intervention: Biobehavioral intervention
Number of subjects: 31
Study 34348349 — intervention group
Group type: EXPERIMENTAL
Intervention: BL algae containing serum
Number of subjects: 60
Study 34348349 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 60
Study 33706052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral negative air pressure device (iNAP)
Number of subjects: 34
Study 34567487 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic local gastrectomy (observation group)
Number of subjects: 86
Study 34567487 — intervention group
Group type: COMPARATOR
Intervention: Radical gastrectomy for benign tumor under laparoscopy (control group)
Number of subjects: 86
Study 34567487 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CEA and CRP levels)
Number of subjects: 86
Study 36189633 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine
Number of subjects: 96
Study 36189633 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% α‐tocopherol
Number of subjects: 96
Study 36189633 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% quercetin
Number of subjects: 96
Study 36189633 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 96
Study 33642330 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX (intravenous injection; 0.5 μg/kg)
Number of subjects: 120
Study 33642330 — intervention group
Group type: EXPERIMENTAL
Intervention: LID (1.5 mg/kg)
Number of subjects: 120
Study 33642330 — intervention group
Group type: COMPARATOR
Intervention: PBO (10 mL normal saline)
Number of subjects: 120
Study 32505213 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CHOP
Number of subjects: 1414
Study 32505213 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 1414
Study 34077602 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined self‐management and exercise programme (treatment group)
Number of subjects: 80
Study 34077602 — intervention group
Group type: COMPARATOR
Intervention: Educational programme (control group)
Number of subjects: 80
Study 34365959 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefrontal Cortex Transcranial direct current stimulation (tDCS) on left dorsolateral prefrontal cortex
Number of subjects: 225
Study 34365959 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefrontal Cortex Transcranial direct current stimulation (tDCS) on left orbitofrontal cortex
Number of subjects: 225
Study 34365959 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 225
Study 35690997 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acetylhexapeptide-8 (AH8) 10% lotion
Number of subjects: 0
Study 35690997 — intervention group
Group type: COMPARATOR
Intervention: Control vehicle lotion
Number of subjects: 0
Study 33401024 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) with adjunct photodynamic therapy (PDT)
Number of subjects: 30
Study 33401024 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone (Control)
Number of subjects: 30